Tradename: VARIVAX
Proper Name: Varicella Virus Vaccine Live
Indication: To include safety and immunogenicity data that supports the intramuscular route as an additional route of administration for VARIVAX, and associated product labeling changes.
VARIVAX is a vaccine indicated for active immunization for the prevention of varicella in individuals 12 months of age and older.
Approval Date: 02/27/2023
Manufacturer: Merck Sharp & Dohme Corp.
More: https://www.fda.gov/vaccines-blood-biologics/vaccines/varivax-refrigerated-and-frozen-formulations